about
Aetiology, diagnosis, and management of hypopituitarism in adult lifeGrowth hormone therapy for people with thalassaemiaTreatment of adult growth hormone deficiency: who, why and how? A reviewThe impact of idiopathic childhood-onset growth hormone deficiency (GHD) on bone mass in subjects without adult GHD.Growth hormone and the heart.Disruption of growth hormone receptor prevents calorie restriction from improving insulin action and longevityAdult height after long term treatment with recombinant growth hormone for idiopathic isolated growth hormone deficiency: observational follow up study of the French population based registry.Genes that prolong life: relationships of growth hormone and growth to aging and life span.Switching to Omnitrope(®) from Other Recombinant Human Growth Hormone Therapies: A Retrospective Study in an Integrated Healthcare System.A dosimetric comparison of proton and intensity modulated radiation therapy in pediatric rhabdomyosarcoma patients enrolled on a prospective phase II proton study.Growth hormone secretion after conformal radiation therapy in pediatric patients with localized brain tumorsEfficacy of needle-free administration of recombinant human growth hormone in adults with growth hormone deficiency.Use of growth hormone for prevention or treatment of effects of aging.Cardiovascular effects of growth hormone treatment: potential risks and benefits.Exploiting Nanobodies in the Detection and Quantification of Human Growth Hormone via Phage-Sandwich Enzyme-Linked Immunosorbent Assay.Transhumanism, medical technology and slippery slopesA Randomized Safety and Efficacy Study of Somavaratan (VRS-317), a Long-Acting rhGH, in Pediatric Growth Hormone DeficiencyModulation of growth hormone receptor abundance and function: roles for the ubiquitin-proteasome system.Pharmacological and physiological growth hormone stimulation tests to predict successful GH therapy in children.The metabolic effects of growth hormone in adipose tissue.Controlled release of bioactive recombinant human growth hormone from PLGA microparticles.One-year GH replacement therapy reduces early cardiac target organ damage (TOD) in adult GHD patients.Optimization of production of recombinant human growth hormone in Escherichia coli.High level expression of recombinant human growth hormone in Escherichia coli: crucial role of translation initiation region.Effects of exogenous growth hormone administration on dexamethasone-induced growth impairment in adolescent male rats.Changes in adiposity and excess body weight correlate with growth responses but not with decreases in low-density lipoprotein cholesterol levels during GH treatment in GH-deficient children.Quantification of osteoblastic activity in epiphyseal growth plates by quantitative bone SPECT/CT.Molecular therapeutic strategies for FGFR3 gene-related skeletal dysplasia.Growth hormone therapy for people with thalassaemia.Polysomnographic findings in five adult patients with pituitary insufficiency before and after cessation of human growth hormone replacement therapy.Effects of 6 years of growth hormone (GH) treatment on bone mineral density in GH-deficient adults.Physiologic Growth Hormone-Replacement Therapy and Craniopharyngioma Recurrence in Pediatric Patients: A Meta-Analysis.Pharmacology of somatrotropin pegylated by electron-beam synthesis nanotechnology.Change of the growth hormone-insulin-like growth factor-I axis in patients with gastrointestinal cancer: related to tumour type and nutritional status.The contribution of IGF-I to skeletal integrity in postmenopausal women
P2860
Q24655732-BA625AC6-1025-47DF-8D38-9B404C6CB183Q26471249-5525D8D7-37DA-486D-885B-89B0F31AA2FAQ28278957-1AFBE561-3337-447C-BB3B-DD16C991BE0BQ31139824-2AF84D0A-8808-4115-A7A6-A4ADA15E1E5EQ32026861-53FD0669-C122-48D1-8CBB-550B57B8B769Q33411289-62500B49-BBC4-4B98-A3B0-B17C053D11B9Q33890606-CCD720B1-100B-435C-BF30-0969DB3ABD31Q34327394-3FB254F6-22F0-4331-920F-850A9E67D9F5Q34627035-32E20638-C837-4188-8F34-9026A833A563Q34984155-0EE1B009-2C18-41AC-BF88-D969A965727AQ35666327-EE120CB3-0234-46EC-9FC9-D3628BD9EA3CQ35827530-7A6CD018-CF53-44D7-97D7-6AA544BE38EEQ35860335-25A41482-0E11-4A9F-AEA1-D7E779B52F19Q35946594-E3170665-5131-4691-98FA-6EF3DD75B443Q36404793-EB819DE2-52E8-43E2-AC5A-AAF4F81E189AQ36581992-E793330A-1920-4FAA-80A3-72DA3D71C079Q36716066-B9D28808-C85E-4951-B1AA-642F27A990F1Q37202220-6453E58B-E747-4352-BD46-D4A018E2166BQ37618697-BC59BF21-84CF-470E-8D64-4ACF8FD31440Q38083594-7F8F6E9D-05E2-43A9-B6C9-921105C45F77Q39670434-97F602F5-686B-470F-B889-B4A037196427Q39852966-F74D05AD-EAA1-4150-B5CB-6CBBCD8E54C4Q42163947-1FF21DC6-ABA4-44F9-8BE9-F93F01BA71D7Q42261209-C47164E2-9BCE-4751-A356-74DD6C59409DQ42376436-D2231425-EA1B-4901-96A7-46F75049CF5CQ44033183-30112AF3-F57D-43A1-B11A-0620308FC1ACQ47554481-20E9DA83-5260-4B1C-8BC9-478C8539EF55Q47612372-13C19E3D-FE4D-442A-A31F-5151F1F04B1CQ47969344-16A1A80F-0868-4927-97BB-90FD89E91072Q48658497-BB8EF4B5-A098-41FA-B3C4-AC9CB42ED26FQ49210518-EA005644-7474-4BFA-8FA8-F878667A8FDDQ49505214-0C050BDD-A0B5-44EF-A174-98680D0E4A29Q53811505-B67AA6EE-9C26-45E6-8F44-02B0F204FE84Q53851028-A1828876-25B3-45F5-AAFA-A0D74D01641DQ58868242-0AC9AD22-04DB-4030-AE2F-272AA51BCB52
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Growth hormone therapy in adults and children.
@ast
Growth hormone therapy in adults and children.
@en
type
label
Growth hormone therapy in adults and children.
@ast
Growth hormone therapy in adults and children.
@en
prefLabel
Growth hormone therapy in adults and children.
@ast
Growth hormone therapy in adults and children.
@en
P1476
Growth hormone therapy in adults and children.
@en
P2093
P304
P356
10.1056/NEJM199910143411607
P407
P577
1999-10-01T00:00:00Z